206 related articles for article (PubMed ID: 8071117)
21. Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
Kingsley EA; Carter TE; Barrow KD; Russell PJ
Cancer Immunol Immunother; 1995 Dec; 41(6):348-54. PubMed ID: 8635192
[TBL] [Abstract][Full Text] [Related]
22. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
24. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
25. Expression of Ca antigen on human urinary bladder tumors.
Czerniak B; Koss LG
Cancer; 1985 May; 55(10):2380-3. PubMed ID: 3886123
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
[TBL] [Abstract][Full Text] [Related]
29. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
Fradet Y; Cordon-Cardo C; Thomson T; Daly ME; Whitmore WF; Lloyd KO; Melamed MR; Old LJ
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):224-8. PubMed ID: 6364135
[TBL] [Abstract][Full Text] [Related]
30. Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
Ben-Aissa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Lundblad ML; Gustafson H; Jonsdottir I; Perlmann P
Br J Cancer; 1985 Jul; 52(1):65-72. PubMed ID: 4015953
[TBL] [Abstract][Full Text] [Related]
31. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
33. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
34. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
[TBL] [Abstract][Full Text] [Related]
35. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
[TBL] [Abstract][Full Text] [Related]
37. Detection of a glycosphingolipid antigen in bladder cancer cells with monoclonal antibody MRG-1.
Kurimoto S; Moriyama N; Takata K; Nozawa S; Aso Y; Hirano H
Histochem J; 1995 Mar; 27(3):247-52. PubMed ID: 7797428
[TBL] [Abstract][Full Text] [Related]
38. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
39. A proliferation-associated rat cell surface antigen recognized by a murine monoclonal antibody.
Hashimoto Y; Masuko T; Yagita H; Endo N; Kanazawa J; Tazawa J
Gan; 1983 Dec; 74(6):819-21. PubMed ID: 6607858
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells.
Arndt R; Dürkopf H; Huland H; Donn F; Loening T; Kalthoff H
J Urol; 1987 Apr; 137(4):758-63. PubMed ID: 3550155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
